Business

Confirmation of Director appointments to the Board

Confirmation of Director appointments to the Board.

articleOptibiotix Health PlcMarch 15, 20173/company/optibiotix-health-plc/news/confirmation-of-director-appointments-to-the-board
Confirmation of Director appointments to the Board

About this update from Optibiotix Health Plc

[{"type":"text","content":"\n \nRNS Number : 4533Z OptiBiotix Health PLC 15 March 2017  \n\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\n15 March 2017\nConfirmation of Director appointments to the Board\n \nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that further to the announcements dated 5 January 2017 and 18 January 2017 and completion of the normal regulatory due diligence, Per Rehné and Christina Wood have been appointed to the Board of OptiBiotix. This follows on from their appointments to the Company in January.\n \nAs previously announced on 5 January 2017, Per has many years' experience of the food industry, having worked for some of the world's leading food companies including most recently Cornelius Group plc where he acted as European Director of Health and Nutrition. \n \nAs announced on 18 January 2017, Christina has 25 years' sales experience within the food, nutrition, and nutraceuticals industry. As the owner and CEO of Confoco, a supplier of high quality food ingredients worldwide, Christina grew the business from £1m to £11m sales by obtaining strategic supplier status with multiple global corporates including Nestlé, Danone, and Heinz.\n \n \nChristina Mary Wood\n \nPursuant to Rule 17 and Schedule Two (g) of the AIM Rules, the following information is disclosed in respect of Christina Mary Wood (aged 57):\n \n\n\n\n\nCurrent Appointments \n\n\nAppointments in the last 5 years\n\n\n\n\n-\n\n\nJohn Morley (Importers) Limited\n\n\n\n\n\n\n\nConfoco International Limited\n\n\n\n\n \nThere is no other information regarding Christina Wood required to be disclosed under the AIM Rules.\n \n \nPer Rehné\n \nPursuant to Rule 17 and Schedule Two (g) of the AIM Rules, the following information is disclosed in respect of Per Rehné (aged 47):\n \n\n\n\n\nCurrent Appointments \n\n\nAppointments in the last 5 years\n\n\n\n\n-\n\n\nCornelius Group Plc\n\n\n\n\n\n\n\nCornelius Nordic APS\n\n\n\n\n\n\n\nCustom Fiber Europe N.V. \n\n\n\n\n\n\n\nRehné Consult 2014 ApS\n\n\n\n\n\n\n\nDJAP Holdings ApS\n\n\n\n\n\n\n\nK/S Welford Place\n\n\n\n\n\n\n\nWelford Place Komplementar ApS\n\n\n\n\n \nMr Rehné was a director of DJAP Holdings ApS which was placed into liquidatio...

More updates from Optibiotix Health Plc